Literature DB >> 7086447

Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases.

H Kuroda, N Ogawa, Y Yamawaki, I Nukina, T Ofuji, M Yamamoto, S Otsuki.   

Abstract

Cerebrospinal fluid gamma-aminobutyric acid (CSF-GABA) was analysed by radioreceptor assay in 16 normal controls and 84 patients with various neurological and psychiatric diseases. In patients with spinocerebellar degeneration, neuro-Behçet's syndrome and Parkinson's disease, CSF-GABA levels were decreased. On the other hand, increased CSF-GABA levels were detected in patients with meningitis.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7086447      PMCID： PMC491348          DOI： 10.1136/jnnp.45.3.257

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  12 in total

1.  Huntington's disease. Cerebrospinal fluid GABA levels in at-risk individuals.

Authors:  N V Manyam; T A Hare; L Katz; B S Glaeser
Journal:  Arch Neurol       Date:  1978-11

Review 2.  Epilepsy and gamma-aminobutyric acid-mediated inhibition.

Authors:  B S Meldrum
Journal:  Int Rev Neurobiol       Date:  1975       Impact factor: 3.230

3.  A simple, sensitive and specific radioreceptor assay for endogenous GABA in brain tissue.

Authors:  S J Enna; S H Snyder
Journal:  J Neurochem       Date:  1976-01       Impact factor: 5.372

Review 4.  Neurobiology and pharmacology of Huntington's disease.

Authors:  S J Enna
Journal:  Life Sci       Date:  1977-01-15       Impact factor: 5.037

5.  Distribution and localization of sites of gamma aminobutyric acid metabolism in the adult rat brain.

Authors:  N Robinson; F Wells
Journal:  J Anat       Date:  1973-04       Impact factor: 2.610

6.  L-glutamic acid decarboxylase in Parkinson's disease: effect of L-dopa therapy.

Authors:  K G Lloyd; O Hornykiewicz
Journal:  Nature       Date:  1973-06-29       Impact factor: 49.962

Review 7.  Biochemical-physiological correlations in studies of the gamma-aminobutyric acid system.

Authors:  E Roberts; K Kuriyama
Journal:  Brain Res       Date:  1968-04       Impact factor: 3.252

8.  Amino acid composition of cerebrospinal fluid in actue neuroinfections in children.

Authors:  A V Buryakova; I A Sytinsky
Journal:  Arch Neurol       Date:  1975-01

9.  Regional distribution of gamma-aminobutyric acid (GABA) in brain of the rhesus monkey.

Authors:  S Fahn; L J Côté
Journal:  J Neurochem       Date:  1968-03       Impact factor: 5.372

10.  Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.

Authors:  N V Manyam; L Katz; T A Hare; J C Gerber; M H Grossman
Journal:  Arch Neurol       Date:  1980-06
View more
  9 in total

Review 1.  Clinical relevance of measuring GABA concentrations in cerebrospinal fluid.

Authors:  P J Schechter; A Sjoerdsma
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

Review 2.  Neurotransmitter-mediated control of neurogenesis in the adult vertebrate brain.

Authors:  Daniel A Berg; Laure Belnoue; Hongjun Song; András Simon
Journal:  Development       Date:  2013-06       Impact factor: 6.868

3.  An endogenous inhibitor of GABA receptor binding.

Authors:  H Kuroda; N Ogawa; I Nukina; Z Ota
Journal:  Neurochem Res       Date:  1984-01       Impact factor: 3.996

4.  Plasma and cerebrospinal fluid gamma-aminobutyric acid in neurological disorders.

Authors:  D Schmidt; W Löscher
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-10       Impact factor: 10.154

5.  Low CSF GABA concentration in children with febrile convulsions, untreated epilepsy, and meningitis.

Authors:  D Rating; H Siemes; W Löscher
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

6.  The response to isoniazid of action tremor in multiple sclerosis and its assessment using polarised light goniometry.

Authors:  D A Francis; D Grundy; J R Heron
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

7.  Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder.

Authors:  Shintaro Ogawa; Kotaro Hattori; Daimei Sasayama; Yuki Yokota; Ryo Matsumura; Junko Matsuo; Miho Ota; Hiroaki Hori; Toshiya Teraishi; Sumiko Yoshida; Takamasa Noda; Yoshiaki Ohashi; Hajime Sato; Teruhiko Higuchi; Nobutaka Motohashi; Hiroshi Kunugi
Journal:  Sci Rep       Date:  2015-01-15       Impact factor: 4.379

Review 8.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

9.  Derivation of a metabolic signature associated with bacterial meningitis in infants.

Authors:  Scott M Gordon; Lakshmi Srinivasan; Deanne M Taylor; Stephen R Master; Marissa A Tremoglie; Adriana Hankeova; Dustin D Flannery; Soraya Abbasi; Julie C Fitzgerald; Mary C Harris
Journal:  Pediatr Res       Date:  2020-03-02       Impact factor: 3.756
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.